IMMUNO-DERMATOLOGY UPDATE - THE IMMUNOLOGICALLY MEDIATED VESICULOBULLOUS DISEASES

被引:18
|
作者
HELM, KF [1 ]
PETERS, MS [1 ]
机构
[1] MAYO CLIN & MAYO FDN, DEPT DERMATOL, ROCHESTER, MN 55905 USA
关键词
D O I
10.1016/S0025-6196(12)60492-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Before a specific diagnosis of an immunologically mediated blistering disease can be made, the clinical and histologic features and the results of direct and indirect immunofluorescence studies (with use of multiple substrates in some cases) must be assessed. For both subepidermal and intraepidermal groups of blistering diseases, direct immunofluorescence testing of perilesional tissue is critical for diagnosis. For these conditions, indirect immunofluorescence testing of serum is important for diagnosis and has a role in management of selected diseases. In dermatitis herpetiformis, indirect testing of serum for IgA antiendomysial antibodies is useful for both diagnosis and management. Indirect testing of serum for IgG antibodies to intercellular substance is important for diagnosis and, in conjunction with the clinical findings, can be used as a guide for monitoring disease activity in patients with pemphigus. Immunoelectron microscopy, immunoprecipitation, and immunoblotting studies have identified the sites of immune deposits and the specific antigens in most of the immunologically mediated bullous diseases. From a practical standpoint, however, direct and indirect immunofluorescence testing, in conjunction with clinical and histologic evaluations, is a simple, rapid, and relatively inexpensive tool for diagnosis and management.
引用
下载
收藏
页码:187 / 202
页数:16
相关论文
共 50 条
  • [21] LONG-TERM PLASMA-EXCHANGE IN IMMUNOLOGICALLY MEDIATED GLOMERULAR-DISEASES
    LUSVARGHI, E
    FURCI, L
    MALMUSI, G
    SAVAZZI, AM
    VANDELLI, L
    BALDINI, E
    GALLI, P
    KIDNEY INTERNATIONAL, 1983, 24 (01) : 133 - 133
  • [22] Levels and avidities of antiphosphatidylethanolamine antibodies in patients with thrombotic events and immunologically-mediated diseases
    Kuchar, Oliver
    Petrackova, Milada
    Kalousova, Marta
    Noskova, Libuse
    Zima, Tomas
    Fialova, Lenka
    BIOMEDICAL PAPERS-OLOMOUC, 2023, 167 (03): : 254 - 262
  • [23] IMMUNOLOGICALLY MEDIATED LUNG-DISEASES - EXTRINSIC ALLERGIC ALVEOLITIS AND ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    SLAVIN, RG
    POSTGRADUATE MEDICINE, 1976, 59 (04) : 137 - 141
  • [24] Nonmicrobial-mediated inflammatory airway diseases—an update
    Polani B. Ramesh Babu
    P. Krishnamoorthy
    Journal of Physiology and Biochemistry, 2014, 70 : 263 - 270
  • [25] HUMAN AND MURINE CUTANEOUS GRAFT-VERSUS-HOST DISEASES - POTENTIAL MODELS FOR THE STUDY OF IMMUNOLOGICALLY MEDIATED SKIN DISEASES
    SAURAT, JH
    PIGUET, PF
    BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 : 213 - 218
  • [26] Nonmicrobial-mediated inflammatory airway diseases-an update
    Babu, Polani B. Ramesh
    Krishnamoorthy, P.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2014, 70 (01) : 263 - 270
  • [27] COEXISTENCE OF IMMUNO-MEDIATED INFLAMMATORY DISEASES: AN ANALYSIS OF THE QUEBEC ADMINISTRATIVE HEALTH DATABASES
    Lachaine, J.
    Beauchemin, C.
    Martel, M. J.
    Parison, D.
    VALUE IN HEALTH, 2011, 14 (07) : A410 - A410
  • [28] Introduction to Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
    Oskouei, Sonia T.
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (12): : S215 - S216
  • [29] Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update
    Ferry, Nicolas
    Pichard, Virginie
    Bony, Dominique Aubert Sebastien
    Tuan Huy Nguyen
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (24) : 2516 - 2527
  • [30] APPLICATION OF IN-111-OXINE IN IMMUNOLOGICALLY-MEDIATED DISEASES - PRELIMINARY INVITRO STUDY IN RHEUMATOID-ARTHRITIS
    MATHIEU, A
    PIGA, M
    MELIS, F
    MADEDDU, G
    PALA, R
    DELGIACCO, GS
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 157 - 158